Global Post-Traumatic Headache Market Size and Share By Industry Demand, Worldwide Research, Prominent Players, Emerging

Post-Traumatic Headache Market Trends Insights and Forecast Research 2021-2027 | Statistics, Competition Strategies, Business Analysis, Opportunities and Share Demand, Global Size and Future Investment Analysis with Covid-19 Impact

The global “post-traumatic headache Market” is expected to witness healthy growth on account of increasing number of vehicular and sports-related accidents. Key insights have been shared by Fortune Business Insights in its report, titled “Post-Traumatic Headache Market Size, Share and Global Trend By Drug Type (Anti-inflammatory drugs, Acetylsalicylic acid, Acetaminophen, Migraine-specific abortant triptan, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography Forecast till 2026”. The report analyses and highlights the important factors driving the market.

Get Sample PDF:

Traumatic Brain Injuries Getting More Attention

Increasing incidents of traumatic brain injuries has forced individuals and organizations to turn their attention towards post-traumatic headaches. The global market is poised to grow as a result during the forecast period. Additionally, increasing instances of vehicular accidents and sports-related head injuries are some of the pivotal factors that are expected to fuel the post-traumatic headache market growth. For example, American Medical Society for Sports Medicine estimates that close 3.8 million concussions occur in America every year due to competitive sports. Rise in migraine cases due to head trauma is seen to be another major driver in the global post-traumatic headache market during the forecast period. Evidence for this has been provided by the American Migraine Foundation which says that around 1.7 million traumatic brain injuries occur every year in America.


Some of the leading companies in the global Post-Traumatic Headache Market:

  • Novartis AG
  • Johnson Johnson Health Care Systems Inc.,
  • Impax Laboratories, LLC.,
  • AstraZeneca,
  • Grunenthal, GlaxoSmithKline plc.,
  • Glenmark Pharmaceutical Inc.,
  • Pfizer Inc.,
  • Merck Co., Inc.

 Headaches can be described as episodes of physical and psychological discomfort. According to medical professionals, headaches are generally a sign of stress or mental distress, and can also be an indication of a medical disorder such as anxiety and depression. Trauma refers to any kind of physical injury that can occur as a result of violence, sports, and accidents. Post-trauma headache refers to a long-lasting headache that a person experiences after an injury to the head. According to the International Headache Society, post-traumatic headache typically occurs within a week of the injury event. Persisting for long periods of time, it is characterised by symptoms such as dizziness, fatigue, loss of concentration, photo sensitivity, and insomnia.

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Browse Complete Report:

131 Puntos de vista